Company name
2022Founder
Nava Therapeutics Nava builds RNA medicines beyond the liver, using modular lipid nanoparticles to deliver therapies precisely to the tissues and cells that need them.
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of July 1, 2026